Anika Therapeutics, Inc. Logo

Anika Therapeutics, Inc.

A global joint preservation company developing solutions for orthopedic care.

ANIK | US

Overview

Corporate Details

ISIN(s):
US0352551081
LEI:
Country:
United States of America
Address:
32 WIGGINS AVENUE, 1730 BEDFORD

Description

Anika Therapeutics, Inc. is a global joint preservation company focused on developing, manufacturing, and marketing solutions for early intervention orthopedic care. The company provides a range of therapeutic products and regenerative solutions designed to treat degenerative orthopedic diseases, traumatic conditions, joint pain, and arthritis. Its portfolio, which utilizes technologies such as hyaluronic acid, aims to restore joint function and enable patients to maintain an active lifestyle. Key products include the Integrity™ Implant System, a regenerative scaffold for tendon augmentation. Anika partners with medical professionals to deliver treatments across the continuum of joint care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 10:21 English 10.0 KB
2025-11-07 07:06 English 11.7 KB
2025-11-05 17:01
FORM S-8
English 66.7 KB
2025-11-05 17:01
FORM 10-Q
English 1.1 MB
2025-11-05 08:20
FORM 8-K
English 132.8 KB
2025-10-17 14:45 English 12.5 KB
2025-07-30 18:12
FORM 10-Q
English 1.1 MB
2025-07-30 09:21
FORM 8-K
English 117.4 KB
2025-07-30 09:15
FORM 8-K
English 83.7 KB
2025-07-24 10:36 English 57.2 KB
2025-07-17 18:28 English 22.5 KB
2025-06-24 19:14 English 7.1 KB
2025-06-24 19:13 English 7.0 KB
2025-06-24 19:13 English 6.9 KB
2025-06-24 19:12 English 7.4 KB

Automate Your Workflow. Get a real-time feed of all Anika Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anika Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Anika Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.